Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

Clinical outcomes of extracorporeal shock wave therapy in patients with secondary lymphedema: a pilot study.

Bae H, Kim HJ.

Ann Rehabil Med. 2013 Apr;37(2):229-34. doi: 10.5535/arm.2013.37.2.229. Epub 2013 Apr 30.

2.

[Influence of local anesthesia and energy level on the clinical outcome of extracorporeal shock wave-treatment of chronic plantar fasciitis].

Labek G, Auersperg V, Ziernhöld M, Poulios N, Böhler N.

Z Orthop Ihre Grenzgeb. 2005 Mar-Apr;143(2):240-6. German.

PMID:
15849646
3.

Extracorporeal Shock Wave Therapy for Breast Cancer-Related Lymphedema: A Pilot Study.

Cebicci MA, Sutbeyaz ST, Goksu SS, Hocaoglu S, Oguz A, Atilabey A.

Arch Phys Med Rehabil. 2016 Sep;97(9):1520-1525. doi: 10.1016/j.apmr.2016.02.019. Epub 2016 Mar 15.

PMID:
26987620
4.

Extracorporeal shock wave therapy combined with vascular endothelial growth factor-C hydrogel for lymphangiogenesis.

Kim IG, Lee JY, Lee DS, Kwon JY, Hwang JH.

J Vasc Res. 2013;50(2):124-33. doi: 10.1159/000343699. Epub 2012 Nov 27.

PMID:
23208012
5.

Prospective trial of complete decongestive therapy for upper extremity lymphedema after breast cancer therapy.

Mondry TE, Riffenburgh RH, Johnstone PA.

Cancer J. 2004 Jan-Feb;10(1):42-8; discussion 17-9.

PMID:
15000494
6.

Extracorporeal shock-wave therapy for supraspinatus calcifying tendinitis: a randomized clinical trial comparing two different energy levels.

Ioppolo F, Tattoli M, Di Sante L, Attanasi C, Venditto T, Servidio M, Cacchio A, Santilli V.

Phys Ther. 2012 Nov;92(11):1376-85. doi: 10.2522/ptj.20110252. Epub 2012 Jun 28.

PMID:
22745199
7.

A first prospective, randomized, double-blind, placebo-controlled clinical trial evaluating extracorporeal shock wave therapy for the treatment of Peyronie's disease.

Palmieri A, Imbimbo C, Longo N, Fusco F, Verze P, Mangiapia F, Creta M, Mirone V.

Eur Urol. 2009 Aug;56(2):363-9. doi: 10.1016/j.eururo.2009.05.012. Epub 2009 May 18. Erratum in: Eur Urol. 2009 Nov;56(5):e43-4.

PMID:
19473751
8.

Extracorporeal shock wave therapy in myofascial pain syndrome of upper trapezius.

Ji HM, Kim HJ, Han SJ.

Ann Rehabil Med. 2012 Oct;36(5):675-80. doi: 10.5535/arm.2012.36.5.675. Epub 2012 Oct 31.

9.

Computed Tomography as an Objective Measurement Tool for Secondary Lymphedema Treated With Extracorporeal Shock Wave Therapy.

Kim SY, Bae H, Ji HM.

Ann Rehabil Med. 2015 Jun;39(3):488-93. doi: 10.5535/arm.2015.39.3.488. Epub 2015 Jun 30.

10.

Extracorporeal shock wave therapy ameliorates secondary lymphedema by promoting lymphangiogenesis.

Kubo M, Li TS, Kamota T, Ohshima M, Shirasawa B, Hamano K.

J Vasc Surg. 2010 Aug;52(2):429-34. doi: 10.1016/j.jvs.2010.03.017.

11.
12.
13.

No effect of extracorporeal shockwave therapy on patellar tendinopathy in jumping athletes during the competitive season: a randomized clinical trial.

Zwerver J, Hartgens F, Verhagen E, van der Worp H, van den Akker-Scheek I, Diercks RL.

Am J Sports Med. 2011 Jun;39(6):1191-9. doi: 10.1177/0363546510395492. Epub 2011 Feb 1.

PMID:
21285447
14.
15.
16.

Extracorporeal shock wave therapy for nonunion of the tibia.

Elster EA, Stojadinovic A, Forsberg J, Shawen S, Andersen RC, Schaden W.

J Orthop Trauma. 2010 Mar;24(3):133-41. doi: 10.1097/BOT.0b013e3181b26470.

PMID:
20182248
17.

Extracorporeal shock wave therapy for the treatment of chronic pelvic pain syndrome in males: a randomised, double-blind, placebo-controlled study.

Zimmermann R, Cumpanas A, Miclea F, Janetschek G.

Eur Urol. 2009 Sep;56(3):418-24. doi: 10.1016/j.eururo.2009.03.043. Epub 2009 Mar 25.

PMID:
19372000
18.

Pole walking for patients with breast cancer-related arm lymphedema.

Jönsson C, Johansson K.

Physiother Theory Pract. 2009 Apr;25(3):165-73. doi: 10.1080/09593980902776621.

PMID:
19384736
19.

Unfocused extracorporeal shock wave therapy as potential treatment for osteoporosis.

van der Jagt OP, van der Linden JC, Schaden W, van Schie HT, Piscaer TM, Verhaar JA, Weinans H, Waarsing JH.

J Orthop Res. 2009 Nov;27(11):1528-33. doi: 10.1002/jor.20910.

20.

Supplemental Content

Support Center